A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
11<br />
86<br />
A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />
Chapter 11: Postexposure Prophylaxis<br />
INTERVENTIONS FOR PEP<br />
IN HEALTH CARE SETTINGS<br />
What types <strong>of</strong> exposures merit consideration<br />
<strong>of</strong> PEP in health care personnel (HCP)?<br />
HCP are at increased risk from percutaneous, mucous<br />
membrane, and nonintact skin exposures <strong>to</strong> bloodborne<br />
pathogens, including hepatitis B, hepatitis C, and <strong>HIV</strong>.<br />
The risk <strong>of</strong> transmission is dependent on many fac<strong>to</strong>rs,<br />
including the type, amount, route, and severity <strong>of</strong><br />
exposure, the infection status <strong>of</strong> the source, and the HBV,<br />
HCV, and <strong>HIV</strong> immunity <strong>of</strong> the exposed worker (see<br />
Tables 11-1 and 11-2).<br />
Table 11-1. High-risk<br />
Occupational Exposures<br />
Exposures <strong>with</strong> higher risk <strong>of</strong><br />
transmission <strong>of</strong> bloodborne pathogens<br />
Deep percutaneous injury<br />
Injury <strong>with</strong> a hollow-bore blood-filled needle<br />
Exposure <strong>to</strong> blood <strong>of</strong> a patient in an advanced disease stage<br />
(high viral load)<br />
Exposure <strong>to</strong> a large quantity <strong>of</strong> blood or body fluids<br />
Table 11-2. Exposures <strong>with</strong> Low Risk <strong>of</strong><br />
Transmission <strong>of</strong> Bloodborne Pathogens<br />
Exposures <strong>with</strong> low risk <strong>of</strong><br />
transmission (PEP not recommended)<br />
Blood or fluid splashes on intact skin<br />
Minor scratches or abrasions <strong>with</strong>out evidence <strong>of</strong> percutaneous<br />
penetration<br />
Penetration by small-bore needles <strong>with</strong>out visible blood<br />
An accurate his<strong>to</strong>ry <strong>of</strong> the exposure is essential in<br />
determining the real risk <strong>of</strong> transmission. In studies,<br />
transmission <strong>of</strong> <strong>HIV</strong> by occupational exposure has an<br />
estimated 0.3% risk <strong>with</strong> percutaneous exposure and<br />
0.09% <strong>with</strong> mucous membrane splash (Bell, 1997).<br />
The risk <strong>of</strong> infection for HBV (in individuals who have<br />
not been vaccinated <strong>to</strong> hepatitis B, or who were vaccine<br />
unresponsive) after percutaneous exposure is 37%-62%<br />
when the source is hepatitis B surface antigen (HbsAg)<br />
positive and hepatitis B e antigen (HBeAg) positive, and<br />
the risk <strong>of</strong> developing clinical hepatitis is 22%-31%.<br />
When the source is HbsAg positive and hepatitis B e<br />
antigen negative, the risk <strong>of</strong> HBV seroconversion is<br />
1%-6%, and the risk <strong>of</strong> developing clinical hepatitis is<br />
23%-37%. The risk <strong>of</strong> transmission is higher, ie 22%-<br />
31%, when the source has clinically evident hepatitis<br />
B hepatitis (Werner and Grady, 1982; CDC, 2001).<br />
Transmission <strong>of</strong> HCV through occupational exposure<br />
carries an average risk <strong>of</strong> 1.8%.<br />
What are immediate actions and initial<br />
considerations in PEP following a possible<br />
occupational exposure?<br />
First aid for the HCP is the first immediate action,<br />
followed by collection <strong>of</strong> information in order <strong>to</strong> assess<br />
the situation and make rapid decisions regarding<br />
appropriate treatment (see Tables 11-3, 11-4, and 11-5).<br />
Quick, expert action by the care provider is essential<br />
because the effectiveness <strong>of</strong> PEP is variable and<br />
depends on the inoculum, type <strong>of</strong> injury, potency <strong>of</strong><br />
the PEP regimen, and speed <strong>with</strong> which treatment is<br />
started. The decision <strong>to</strong> prescribe medications, as well<br />
as medication administration, should be made <strong>with</strong>in<br />
4 hours <strong>of</strong> the exposure, and must be made <strong>with</strong>in<br />
72 hours, and preferably sooner because <strong>of</strong> studies<br />
suggesting that the efficacy <strong>of</strong> PEP is diminished after<br />
36 hours. Even <strong>with</strong> optimal implementation, ie <strong>with</strong>in<br />
the first 4 hours, the protection afforded by PEP is not<br />
100%.<br />
What counseling and education should you<br />
give the HCP?<br />
The exposed HCP needs immediate counseling <strong>to</strong><br />
assist in coping <strong>with</strong> the emotional stress <strong>of</strong> the<br />
exposure, and may require follow up care by a mental<br />
health pr<strong>of</strong>essional. Psychological services should be<br />
available 24 hours a day, 7 days a week. A local crisis<br />
management team or an employee assistance program<br />
(EAP) may be effective ways <strong>to</strong> address this need.<br />
The HCP should be <strong>to</strong>ld the relative risk <strong>of</strong> infection<br />
<strong>with</strong> <strong>HIV</strong>, HBV, and HCV following exposure, the<br />
effectiveness <strong>of</strong> PEP, and the risks and benefits <strong>of</strong><br />
PEP. Exposed persons should be advised <strong>to</strong> return<br />
immediately if symp<strong>to</strong>ms <strong>of</strong> acute <strong>HIV</strong> seroconversion<br />
occur, including fever, malaise, rash, swollen lymph<br />
nodes, fatigue or myalgias (most likely <strong>to</strong> occur 2-6<br />
weeks after exposure).<br />
Providers should advise exposed HCPs <strong>to</strong> prevent<br />
transmitting <strong>HIV</strong> <strong>to</strong> others, by means <strong>of</strong> the following<br />
measures, until the HCP has a negative <strong>HIV</strong> test 6<br />
months after exposure:<br />
• Refrain from donating blood, plasma, organs, tissue,<br />
or semen.<br />
• Use barrier protection during sexual activity.<br />
• If HCP is female, avoid pregnancy.<br />
• If breast feeding, consider discontinuing, <strong>to</strong> avoid the<br />
risk <strong>of</strong> <strong>HIV</strong> transmission through breast milk.<br />
If exposed <strong>to</strong> HBV, the HCP should follow infection<br />
control procedures that are in place at the institution.<br />
U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau